慢性中心性浆液性脉络膜视网膜病变的长期视力结局与视力丧失原因
该回顾性纵向研究纳入133例(217眼)慢性中心性浆液性脉络膜视网膜病变(CSC)患者,随访平均11.3年,发现79.7%患者至少一眼维持20/40或更好视力,12.8%双眼法律盲;首次就诊年龄及OCT外层视网膜改变与长期视力变化相关。
要点
- 慢性CSC可威胁视力,12.8%患者最终双眼法律盲(BCVA≤20/200)。
- 首次BCVA≥20/40的眼在10年时79%维持相同视力水平。
- 囊样黄斑变性、CNV、OCT外层视网膜破坏及FAF改变与最终视力较差相关。
核心结论
- 慢性CSC可导致法律盲,首次就诊年龄及多模态成像上的外层视网膜改变与长期BCVA变化相关,可能预测长期视力结局。
研究设计与样本
- 回顾性纵向研究,纳入133例(217眼)慢性CSC患者,分析1977年5月至2018年3月由3位作者管理的临床及多模态影像数据。
主要发现
- 共分析6228次门诊访视数据,首次就诊平均年龄60.7岁,平均随访11.3年,男性101例(75.9%)。
- 最终访视时106例(79.7%)至少一眼BCVA≥20/40(驾驶标准),17例(12.8%)双眼BCVA≤20/200(法律盲)。
- 首次BCVA与1年、5年随访无显著差异(均P≥0.65),但显著优于10年随访(P=0.04)。
- 囊样黄斑变性、脉络膜新生血管(CNV)、OCT外层视网膜破坏及FAF改变与最终视力较差相关(均P≤0.001);多变量分析显示首次就诊年龄较大与10年随访BCVA变化较大相关(P=0.001)。
临床怎么用
- 对慢性CSC患者应长期随访,关注首次就诊年龄及多模态影像中的外层视网膜改变,以评估视力预后。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the long-term visual outcomes and causes of vision loss in chronic central serous chorioretinopathy (CSC). DESIGN: Retrospective, longitudinal study. PARTICIPANTS: A total of 133 participants (217 eyes) with chronic CSC. METHODS: A retrospective review of clinical and multimodal imaging data of patients with chronic CSC managed by 3 of the authors between May 1977 and March 2018. Multimodal imaging comprised color photography, fluorescein angiography, indocyanine green angiography, fundus autofluorescence (FAF), and OCT. MAIN OUTCOME MEASURES: Best-corrected visual acuity (BCVA) at the final visit; change in BCVA between first visit and 1-, 5-, and 10-year follow-up visits; and causes of vision loss at final visit. RESULTS: Data from 6228 individual clinic visits were analyzed. Mean age of patients at the first visit was 60.7 years, and mean period of follow-up from first to last visit was 11.3 years. The cohort included 101 male patients (75.9%). At the final visit, 106 patients (79.7%) maintained driving-standard vision with BCVA of 20/40 or better in at least 1 eye, and 17 patients (12.8%) were legally blind with BCVA of 20/200 or worse in both eyes. Mean BCVA at first visit was not significantly different from mean BCVA at 1- or 5-year follow-up visits (both P ≥ 0.65) but was significantly better than the mean BCVA at the 10-year follow-up visit (P = 0.04). Seventy-nine percent of eyes with 20/40 or better vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Ninety-two percent of eyes with 20/200 or worse vision at the first visit maintained the same level of vision at the 10-year follow-up visit. Cystoid macular degeneration, choroidal neovascularization (CNV), outer retinal disruption on OCT, and FAF changes were associated with poorer vision at the final visit (all P ≤ 0.001). Multivariable analysis revealed that greater age at first visit was associated with greater BCVA change at the 10-year follow-up visit (P = 0.001). CONCLUSIONS: Chronic CSC can be a sight-threatening disease leading to legal blindness. Age at presentation and outer retinal changes on multimodal imaging were associated with long-term BCVA changes and may be predictors of long-term visual outcomes.
引用
- Mrejen S, Balaratnasingam C, Kaden TR, et al. Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy. Ophthalmology. 2019. PMID: 30659849. doi:10.1016/j.ophtha.2018.12.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。